NM_014141.6:c.97+248844T>G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_014141.6(CNTNAP2):​c.97+248844T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.228 in 152,068 control chromosomes in the GnomAD database, including 4,872 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.23 ( 4872 hom., cov: 32)

Consequence

CNTNAP2
NM_014141.6 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.314

Publications

2 publications found
Variant links:
Genes affected
CNTNAP2 (HGNC:13830): (contactin associated protein 2) This gene encodes a member of the neurexin family which functions in the vertebrate nervous system as cell adhesion molecules and receptors. This protein, like other neurexin proteins, contains epidermal growth factor repeats and laminin G domains. In addition, it includes an F5/8 type C domain, discoidin/neuropilin- and fibrinogen-like domains, thrombospondin N-terminal-like domains and a putative PDZ binding site. This protein is localized at the juxtaparanodes of myelinated axons, and mediates interactions between neurons and glia during nervous system development and is also involved in localization of potassium channels within differentiating axons. This gene encompasses almost 1.5% of chromosome 7 and is one of the largest genes in the human genome. It is directly bound and regulated by forkhead box protein P2, a transcription factor related to speech and language development. This gene has been implicated in multiple neurodevelopmental disorders, including Gilles de la Tourette syndrome, schizophrenia, epilepsy, autism, ADHD and intellectual disability. [provided by RefSeq, Jul 2017]
CNTNAP2 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AR, AD Classification: DEFINITIVE, NO_KNOWN Submitted by: ClinGen
  • cortical dysplasia-focal epilepsy syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Illumina, Labcorp Genetics (formerly Invitae), Orphanet, G2P, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.383 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CNTNAP2NM_014141.6 linkc.97+248844T>G intron_variant Intron 1 of 23 ENST00000361727.8 NP_054860.1
CNTNAP2XM_017011950.3 linkc.97+248844T>G intron_variant Intron 1 of 13 XP_016867439.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CNTNAP2ENST00000361727.8 linkc.97+248844T>G intron_variant Intron 1 of 23 1 NM_014141.6 ENSP00000354778.3
CNTNAP2ENST00000625365.2 linkc.97+248844T>G intron_variant Intron 2 of 3 5 ENSP00000485955.1
CNTNAP2ENST00000637150.1 linkn.26+248844T>G intron_variant Intron 1 of 8 5

Frequencies

GnomAD3 genomes
AF:
0.228
AC:
34694
AN:
151948
Hom.:
4862
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0767
Gnomad AMI
AF:
0.305
Gnomad AMR
AF:
0.391
Gnomad ASJ
AF:
0.225
Gnomad EAS
AF:
0.311
Gnomad SAS
AF:
0.147
Gnomad FIN
AF:
0.228
Gnomad MID
AF:
0.250
Gnomad NFE
AF:
0.282
Gnomad OTH
AF:
0.251
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.228
AC:
34713
AN:
152068
Hom.:
4872
Cov.:
32
AF XY:
0.227
AC XY:
16853
AN XY:
74340
show subpopulations
African (AFR)
AF:
0.0765
AC:
3177
AN:
41530
American (AMR)
AF:
0.392
AC:
5973
AN:
15248
Ashkenazi Jewish (ASJ)
AF:
0.225
AC:
781
AN:
3468
East Asian (EAS)
AF:
0.311
AC:
1607
AN:
5164
South Asian (SAS)
AF:
0.147
AC:
708
AN:
4826
European-Finnish (FIN)
AF:
0.228
AC:
2402
AN:
10556
Middle Eastern (MID)
AF:
0.259
AC:
76
AN:
294
European-Non Finnish (NFE)
AF:
0.282
AC:
19186
AN:
67956
Other (OTH)
AF:
0.248
AC:
525
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1312
2624
3935
5247
6559
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
356
712
1068
1424
1780
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.130
Hom.:
241
Bravo
AF:
0.241
Asia WGS
AF:
0.248
AC:
859
AN:
3476

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
2.1
DANN
Benign
0.61
PhyloP100
0.31
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12703803; hg19: chr7-146062909; API